Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts

[1]  L. Schneider,et al.  A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. , 2003, Current drug targets.

[2]  F. Leuven,et al.  Secretases as targets for the treatment of Alzheimer's disease: the prospects , 2002, The Lancet Neurology.

[3]  S. Shiu,et al.  The effects of melatonin and Ginkgo biloba extract on memory loss and choline acetyltransferase activities in the brain of rats infused intracerebroventricularly with beta-amyloid 1-40. , 2002, Life sciences.

[4]  Y. Christen,et al.  What is Ginkgo biloba extract EGb 761? An overview--from molecular biology to clinical medicine. , 2002, Cellular and molecular biology.

[5]  R. Quirion,et al.  EGb 761 is a neuroprotective agent against beta-amyloid toxicity. , 2002, Cellular and molecular biology.

[6]  M. Luca,et al.  α-Secretase ADAM10 as Well as αAPPs Is Reduced in Platelets and CSF of Alzheimer Disease Patients , 2002, Molecular medicine.

[7]  L. Ma,et al.  Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. , 2001, The Biochemical journal.

[8]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Quirion,et al.  The Ginkgo biloba Extract (EGb 761) Protects and Rescues Hippocampal Cells Against Nitric Oxide‐Induced Toxicity , 2000, Journal of neurochemistry.

[10]  Y. Christen,et al.  The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloid , 2000 .

[11]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[12]  Alfredo G. Tomasselli,et al.  Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.

[13]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[14]  C. Blobel,et al.  Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. , 1999, The Biochemical journal.

[15]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[16]  K. Suzuki,et al.  Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. , 1999, The Biochemical journal.

[17]  M. Racchi,et al.  Activity of α‐Secretase as the Common Final Effector of Protein Kinase C‐Dependent and ‐Independent Modulation of Amyloid Precursor Protein Metabolism , 1999, Journal of Neurochemistry.

[18]  E. Kojro,et al.  Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Joseph D. Buxbaum,et al.  Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor* , 1998, The Journal of Biological Chemistry.

[20]  Yutaka Kirino,et al.  Cleavage of Alzheimer’s Amyloid Precursor Protein (APP) by Secretases Occurs after O-Glycosylation of APP in the Protein Secretory Pathway , 1998, The Journal of Biological Chemistry.

[21]  Turan M. Itil,et al.  A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia , 1997 .

[22]  L. Harrell,et al.  Cholinergic activity and amyloid precursor protein metabolism , 1997, Brain Research Reviews.

[23]  L. Mucke,et al.  Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo , 1997, Neuroscience.

[24]  P. Greengard,et al.  Amyloid beta peptide formation in cell-free preparations. Regulation by protein kinase C, calmodulin, and calcineurin. , 1996, The Journal of biological chemistry.

[25]  Ch Lai,et al.  The Effect of Cholinesterase Inhibitors on the Secretion of APPS from Rat Brain Cortex a , 1996, Annals of the New York Academy of Sciences.

[26]  S. Farber,et al.  Regulated secretion of beta-amyloid precursor protein in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  P. Greengard,et al.  Regulated Formation of Golgi Secretory Vesicles Containing Alzheimer β-Amyloid Precursor Protein (*) , 1995, The Journal of Biological Chemistry.

[28]  B. Hofferberth,et al.  The efficacy of EGb 761 in patients with senile dementia of the alzheimer type, a double‐blind, placebo‐controlled study on different levels of investigation , 1994 .

[29]  D. Selkoe,et al.  Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide , 1993, Cell.

[30]  N. Bazan,et al.  Decreased Electroconvulsive Shock‐Induced Diacylglycerols and Free Fatty Acid Accumulation in the Rat Brain by Ginkgo biloba Extract (EGb 761): Selective Effect in Hippocampus as Compared with Cerebral Cortex , 1993, Journal of neurochemistry.

[31]  P. Greengard,et al.  Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Growdon,et al.  Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. , 1992, Science.

[33]  S. Younkin,et al.  Secretory processing of the Alzheimer amyloid beta/A4 protein precursor is increased by protein phosphorylation. , 1992, Biochemical and biophysical research communications.

[34]  S. Sisodia.  Beta-amyloid precursor protein cleavage by a membrane-bound protease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Samuel Thayer,et al.  Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[37]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[39]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.